Topic: Medtronic Inc.
NEW ORLEANS (Reuters) - Sophisticated devices and nonsurgical techniques look to be the wave of the future in the battle against heart disease as drugmakers produce fewer new medicines to fight the world's leading cause of death.Signs of the trend were evident ...
NEW ORLEANS (Reuters) - Medtronic Inc's Resolute drug-coated stent met the main safety goals of a large study of U.S. patients, providing the final data the company expects to need to seek U.S. approval of its next generation heart device.The Resolute stent, ...
CHICAGO/NEW YORK (Reuters) - A potential breakthrough heart valve from Edwards Lifesciences Corp that can spare patients from chest-cracking, open heart surgery will take center stage at one of the year's most important heart meetings this weekend.Tens of thousands of cardiologists and ...
NEW YORK (Reuters) - Medical device maker Medtronic Inc said U.S. regulators approved its new catheter system for treating a common heart rhythm disorder known as paroxysmal atrial fibrillation.The Food and Drug Administration approved the Arctic Front Cardiac CryoAblation Catheter system, a ...
CHICAGO (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that shocks the heart if needed, according to new data that support use of the ...
New clinical data from a second, large international study that enrolled "all comers," regardless of disease complexity and comorbidities, again demonstrated the strong performance of the Resolute drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), for patients across this continuum. The findings ...
If you want a heart-valve replacement without having your chest split open, you'll have to go to Europe. It had 70% growth in Sapien sales for 2010, says analyst Spencer Nam of Madison Williams & Co.. For 2010, sales will likely hit ...
Medtronic says study highlights catheter speed for treating atrial fibrillationMedical device maker Medtronic Inc. said Friday late-stage study data shows two catheters it is seeking approval for in the United States work faster than a traditional approach in helping doctors treat forms ...
Patients who are hospitalized for heart failure are unlikely to have early follow-up after discharge, but those who are discharged from hospitals that have a higher rate of following up within one week have a lower risk of being readmitted within 30 ...
Medtronic to buy heart surgery device maker ATS Medical for $350 millionMedical device company Medtronic Inc. said Thursday it has agreed to buy heart device maker ATS Medical Inc. for $350 million in cash, expanding its products for cardiac surgery.Medtronic is offering ...